Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Accelerates Topline Results from NCX 470 Mont Blanc Phase 3 Glaucoma Trial to November 2022

June 3, 2022

View Press Release Corporate presentation Contact us
Previous